Translational Development Acquisition Corp. (TDAC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TDAC currently has 17.3M outstanding shares. with significant dilution risk as 39.4M authorized shares could dilute existing holders by 228.4%. The company has significantly diluted shareholders by 270.37% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 30, 2026 |
10-K filing | 17.3M shares outstanding |
17M | 39M |
| Nov 14, 2025 |
10-Q filing | 17.3M shares outstanding |
17M | 39M |
| May 15, 2025 |
10-Q filing | 17.3M shares outstanding |
17M | 39M |
| Mar 31, 2025 |
10-K filing | 4.7M shares outstanding |
4.7M | 39M |
| Dec 27, 2024 |
8-K filing: Translational Development Acquisition Corp. consummated its initial public offering of 17,250,000 units at $10.00 per unit, generating gross proceeds of $172,500,000, and completed the private placement of 7,075,000 warrants to the Sponsor and the Underwriter at $1.00 per warrant, for gross proceeds of $7,075,000. ($179.58M proceeds) |
4.7M | 39M |
| Dec 19, 2024 |
S-1/A filing: Initial public offering of units by Translational Development Acquisition Corp., a blank check company, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, along with a concurrent private placement of warrants. |
4.7M | 39M |
| Nov 20, 2024 |
S-1/A filing: Translational Development Acquisition Corp. is offering 15,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, in an initial public offering. |
4.7M | 39M |
| Oct 22, 2024 |
S-1 filing: Translational Development Acquisition Corp. is offering 15,000,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and one-half of one redeemable warrant, along with private placement warrants to be purchased by the sponsor and BTIG, LLC. |
4.7M | 39M |
| Aug 26, 2022 |
S-1 filing: Translational Development Acquisition Corp. is offering 15,000,000 units at $10.00 per unit for a total of $150,000,000 in an initial public offering. Each unit consists of one ordinary share and one-half of one redeemable warrant. |
N/A | 18M |